Summary Wnt genes are transforming to mouse breast epithelium and are hormonally regulated in vivo. To assess their role in another endocrine-responsive human cancer, the expression of seven Wnt genes (Wnt 2, 3, 4, 5a, 7a, 7b and 1 Ob) in normal human endometrium and endometrial cells, and endometrial carcinoma tissues and cell lines was investigated by ribonuclease protection analysis. Wnt2, 3, 4 and 5a mRNAs but not Wnt7a, 7b or 10b mRNAs were expressed in primary culture of normal endometrial epithelial (NEE) and stromal (NES) cells. In contrast, in four endometrial carcinoma cell lines (RL95-2, HEC-1 -A, AN3 CA and Ishikawa), Wnt2 and Wnt3 mRNAs were absent. Wnt4 was expressed in only one out of four cell lines (RL95-2), and Wnt5a was much lower. Wnt7a and Wnt7b mRNAs were expressed in three out of four cell lines (RL95-2, HEC-1 -A and Ishikawa). WntlOb mRNA was expressed in RL95-2 and AN3 CA. In fresh tissues, all Wnt genes apart from WntlOb were expressed in normal endometrium and endometrial carcinoma. Similar to the cell lines, the level of Wnt4 mRNA expression was significantly higher in the normal endometrium than endometrial carcinoma. Wnt2, 3 and 5a mRNAs were also lower in endometrial carcinoma compared with normal endometrium. There was no difference in the level of Wnt2, 3, 4 and 5a mRNA expression between proliferative phase and secretory phase of the menstrual cycle, or between either menstrual phase and the first trimester of pregnancy. In vitro, progesterone and/or 1 7,l-oestradiol had no effect on Wnt2, 3, 4, 5a and 7b mRNA expression in NES and all endometrial carcinoma cell lines. The data indicate that all Wnt genes were expressed in vitro, six out of seven Wnt genes (Wnt 2, 3, 4, 5a, 7a and 7b) were expressed endogenously in the human endometrium, their mRNA expression was hormonally independent and Wnt4 gene downregulation as well as down-regulation of Wnt 2, 3 and 5a may be associated with endometrial carcinoma.
Wnt genes make up a large family of highly conserved developmental genes. The first member, int-1, was discovered as a common integration site of mouse mammary tumour virus (MMTV) in mammary epithelial adenocarcinomas (Nusse and Varmus, 1992) . Int-i exhibits a high homology to the Drosophila developmental gene wingless that is involved in pattern formation. The combination of wingless and int-i gives rise to the term Wnt so that int-I became Wntl and is the first member of the Wnt gene family (Nusse et al, 1991) . In the MMTV-induced mouse mammary carcinoma, two additional Wnt3 and WntlOb genes are also known to be activated concomitantly with FGF3 and FGF8 genes, respectively, indicating members of the Wnt and FGF families act co-operatively to induce tumorigenesis (Roelink et al, 1990 ; Lee et al, 1995) . On its own, Wntl is capable of inducing mammary hyperplasia and carcinoma that are unaffected by ovariectomy and adrenalatomy in both transgenic male and female mice Edwards et al, 1992) . In the presence of FGF3, the rate of Wntl-induced mouse mammary hyperplasia is increased indicating the role of FGF in accelerating tumorigenesis (Kwan et al, 1992) . Evidence from the in vitro studies has also demonstrated the ability of some Wnt genes (Wntl, 2, 3a, 5b, 7a and 7b) to cause partial transformation in the mouse mammary epithelial cell line, C57MG (Wong et al, 1994) and Wntl, 6 and 7b in the mouse embryonic fibroblast cell line, C3H 1OT1/2 (Bradbury et al, 1994) . A subset of the murine Wnt genes (Wnt2, 4, Sa, Sb, 6 and 7b) has been found to be expressed differentially in virginal, pregnant, lactating and involuting mammary tissues (Gavin et al, 1992; Buhler et al, 1993; Weber-Hall et al, 1994) .
Furthermore, Wnt2, Wnt4 and Wnt5b are regulated by ovarian hormones indicating the role of Wnts in the normal development of the mouse mammary gland.
Homologues of mouse Wnt genes have been isolated in Drosophila, Xenopus, chicken and humans (Nusse and Varmus, 1992) . In humans, there are nine Wnt genes known [Wntl (van Ooyen et al, 1985) , Wnt2 (Wainright et al, 1988) , Wnt3 (Roelink et al, 1993) , Wnt5a (Clark et al, 1993; Lejeune et al, 1995) , Wnt3a, Wnt4, Wnt7a and Wnt7b (Huguet et al, 1994) , and WntlOb (Bui et al, 1997a) ]. Four Wnt genes (Wnt2, 4, Sa and 7b) are more highly expressed in human breast carcinomas compared with normal breast tissues (Huguet et al, 1994; Lejeune et al, 1995) . Additionally, Wnt5a is also up-regulated in lung, colon and prostate carcinomas and melanomas (Jozzo et al, 1995) , Wnt2 is up-regulated in colon carcinomas (Vider et al, 1996) and Wnt7b is up-regulated in superficial bladder carcinomas compared with normal bladder tissues and invasive bladder carcinomas (Bui et al, 1997b) . This accumulating evidence supports the role of Wnt genes in the development of human malignancy.
In the mouse uterus, Wnt5a is expressed in the uterine mesenchyme but not in the uterine or vaginal epithelium, and is required for the induction of the homeobox-containing gene, MsxJ, in Mullerian epithelium. The MsxJ gene, in turn, plays an important role in maintaining the adult uterus in a morphogenetic and developmentally responsive state (Pavlova et al, 1994 ). The expression of Wnt genes in the human uterus has not yet been reported. Therefore, the aim of this study was to examine the expression of seven Wnt genes in normal human endometrium, primary cultures of endometrial cells, endometrial carcinoma tissues and cell lines in order to evaluate hormonal regulation in the human endometrium and differential expression in endometrial cancer.
MATERIALS AND METHODS
Primary cells, cell lines, tissue samples and RNA preparation The primary normal human endometrial epithelial (NEE) and stromal (NES) cells were isolated and maintained as described (Zhang et al, 1995) . The human endometrial carcinoma cell lines were obtained from the American Type Culture Collection, Bethesda, MD, USA: RL95-2 (CRL 1671), HEC-1-A (HTB 112) and AN3 CA (HTB 111); and Ishikawa from Dr John White (Hammersmith Hospital, London, UK). The normal human endometrium and endometrial carcinoma samples were obtained at hysterectomy, frozen immediately and stored in liquid nitrogen until required. The stage of the menstrual cycle of the tissue was determined from the patient's menstrual history and endometrial histology (Noyes et al, 1950; Ferenczy, 1987; Buckley and Fox, 1989) . Human first trimester decidua was obtained at termination of pregnancy and stored in liquid nitrogen until required. All the cells were cultured in Dulbecco's modified Eagle medium (DMEM) (Imperial Cancer Research Fund Clare Hall Laboratories, UK) and 10% fetal calf serum (FCS; Globepharm), on plastic culture plates (Becton Dickinson) at 37°C, 5% carbon dioxide/95% air, in a humidified incubator. The cells were allowed to reach confluence before harvest. Total RNA was prepared from tissues and cells using the acid guanidium thiocyanate-phenol-chloroform extraction method as described (Chomczynski and Sacchi, 1987) , followed by a 5.7 M caesium chloride separation in polyallomer tubes (13 x 5 1mm; Beckman) at 50 000 r.p.m. for 3 h using SW50 or SW55 swing rotor (Beckman) in the L8-80M ultracentrifuge (Beckman). The RNA pellet was resuspended in 200 tl of sterile water, treated with RNAase-free DNAase at 37°C for 15 min, extracted with an equal volume of phenol, ethanol precipitated with 0.1 x volume of sodium acetate, pH 5.2, and resuspended in water to the final concentration of 1 [ig RI-'. Treatment of cells with progesterone and 17p-oestradiol Cells were grown to confluence and then allowed to quiesce for 1 week in oestrogen-free medium containing phenol red-free DMEM/10% dextran-coated charcoal-stripped FCS. Cells were then treated with fresh oestrogen-free medium containing either 5 x l0-Y M progesterone (Sigma) or 5 x 10-'°M 17p3-oestradiol (Sigma) for 18 h. Total RNA was harvested from cells as described above.
Riboprobe constructs and ribonuclease (RNAase) protection analysis
The human Wnt 2, 3, 4, 7a and 7b (Huguet et al, 1994) , Wnt5a (Lejeune et al, 1995) , Wnt lOb (Bui et al, 1997b) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (McCarthy and Bicknell, 1992) riboprobe constructs have been described. The linearized plasmid DNA was labelled with a[32P]CTP (Amersham) to generate antisense riboprobe, which was then purified using the Spin Column according to the manufacturer's instructions (Boehringer Mannheim). RNAase protection analysis was performed using standard protocols (Ausubel et al, 1990 
Statistical analysis
The level of expression of all the Wnts in human endometrial tissues and endometrial tumours were compared using the Student unpaired t-test, using the Minitab version 8.2.
RESULTS
The expression of Wnt mRNAs in normal human endometrial cells and endometrium, and endometrial carcinoma cell lines and endometrial tumours was determined by RNAase protection analysis.
Expression of Wnt mRNAs in normal human endometrial cells and endometrial cells and endometrial carcinoma cell lines (Zhang et al, 1995) . fragment. A representative autoradiograph ( Figure 1A) shows a specific Wnt5a mRNA protected fragment and corresponding GAPDH mRNA protected fragment in endometrial cells. The data show that Wnt2, 3, 4 and 5a mRNAs were expressed at higher levels in normal endometrial cells than endometrial carcinoma cell lines; whereas Wnt7a, 7b and 10b mRNAs were absent in normal endometrial cells but expressed in some endometrial carcinoma cell lines.
Expression of Wnt mRNAs in human endometrium and endometrial carcinoma The Wnt mRNA expression was then assessed in intact human endometria and endometrial tumours. Four normal human endometrial samples were from the proliferative phase (P) and seven from the secretory phase (S). Four human endometrial carcinomas were at the superficial stage I and grade II of the disease in which the tumour was confined within the uterus. The Wnt mRNA expression values were obtained as a ratio of the optical density value of Wnt protected fragment signal to the optical density value of GAPDH protected fragment signal of the same sample carried out in the same assay. P, S and C refer to proliferative phase, secretory phase and carcinoma respectively.
British Journal of Cancer (1997) 75(8), [1131] [1132] [1133] [1134] [1135] [1136] Expression of Wnt mRNAs in human endometria at proliferative phase and secretory phase and from the first trimester
It has been reported that ovariectomized mice exhibited a slight reduction (20-40%) in Wnt2, Wnt4 and Wnt5b mRNA levels in mammary gland compared with control mice (Weber-Hall et al, 1994) . Therefore, the effect of ovarian hormones on Wnt mRNA expression was investigated in human endometria during the menstrual cycle and first trimester. Six human endometria were in the first trimester of pregnancy. Figure 2 summarizes Wnt2, 3, 4 and 5a mRNA levels in the human endometria at three different stages. Wnt2, 3, 4 and 5a were strongly expressed in all the tissues. Wnt7a and Wnt7b were expressed at a low level. WntlOb was not expressed. Figure 3 is Wnt2, 3, 4 and 5a mRNA expression between the proliferative phase and secretory phase of the menstrual cycle, or between either the menstrual phase and first trimester (result not shown).
The data show that in vivo ovarian hormones had no effect on the Wnt mRNA expression investigated.
Hormonal effect on Wnt mRNA expression in vitro in NES and endometrial carcinoma cell lines
The effect of ovarian hormones on Wnt mRNA expression was also investigated in vitro. After 18 h hormonal treatment at a physiological concentration of progesterone or oestrogen, there was no difference in the levels of Wnt2, 3, 4, 5a and 7b mRNAs between control and progesterone and/or 1713-oestradiol-treated cells. However, mRNA for vascular endothelial growth factor and midkine was also studied and was induced at 18 h (Zhang et al, 1995) . Figure 4 is a representative autoradiograph showing a specific Wnt5a mRNA protected fragment and corresponding GAPDH mRNA protected fragment in control and hormonaltreated cells. The data show that progesterone and 17p-oestradiol had no effect on the Wnt mRNA expression investigated in vitro, although other hormonal-regulated genes responded.
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DISCUSSION
There is emerging evidence indicating that Wnt genes may play a role in the genesis of human malignancy, and different Wnt genes are involved in different tumour types (Huguet et al, 1994; lozzo et al, 1995; Lejeune et al, 1995; Vider et al, 1996) . We analysed Wnt mRNA expression in human endometrium and endometrial carcinoma cell lines derived from and in fresh tissues. The level of Wnt4 mRNA expression was significantly higher in normal endometrium than endometrial carcinoma, suggesting that Wnt4 down-regulation might be important in the development of endometrial cancer. This down-regulation of Wnt4 mirrors that seen following morphological transformation of C57MG cells induced by Wntl or Wnt2 or activated neu tyrosine kinase receptor (Olson and Papkoff, 1994) . Three out of the four endometrial carcinoma samples also expressed lower Wnt2, 3 and 5a mRNA levels compared with normal endometrium, suggesting these genes may also have a role in normal differentiation. In all the known differentially expressed Wnts, this is the first case in which a Wnt gene is down-regulated by at least sixfold in human tumour tissues compared with normal tissues. It was possible that the difference in Wnt mRNA expression between normal endometrium and endometrial carcinoma was caused by different responses to ovarian hormones. This has been demonstrated in the mouse mammary gland in which Wnt2, 4 and Sb were slightly down-regulated by ovarian hormones (WeberHall et al, 1994) . The data obtained from the endometria in the proliferative phase and secretory phase of the menstrual cycle and in the first trimester of pregnancy in which the levels of oestrogen and progesterone vary dramatically, showed no variation in mRNA expression of Wnt2, 3, 4 and Sa. Additionally, the in vitro data show that hormonal treatment had no effect on the mRNA expression of these Wnt genes plus Wnt7b.
Since the endometrium consists of a mixture of different cell populations, largely epithelia and stroma, it is possible that the level of Wnt mRNA expression might relate to the ratio of epithelia to stroma, as is seen in the mouse uterus in which Wnt5a is expressed endogenously in the uterine mesenchyme, which then acts on the neighbouring uterine epithelia to induce expression of a homeobox-containing gene, Msx-J, for uterine development (Pavlova et al, 1994) . Using highly homogeneous isolated primary normal endometrial epithelial and stromal cells (Zhang et al, 1995) , Wnt2, 3, 4 and 5a mRNAs were shown to be expressed more highly in the normal human endometrial cultures, NES and NEE, compared with endometrial carcinoma cell lines. The expression of Wnt2, 3, 4 and 5a genes in tum reflected the Wnt expression seen in vivo. Therefore, the predominant cell types isolated from normal endometrium exhibited a different phenotype from the tumours. However, it could not be excluded that a minor population of normal endometrial cells also had the same phenotype as the tumours, which could give rise to the differential Wnt2, 3, 4 and 5a expression between normal endometrial cells and endometrial carcinoma cell lines.
In vitro, Wnt7a and Wnt7b were detected in endometrial carcinoma cell lines but not in normal endometrial cultures. In comparison with in vivo, both Wnt7a and Wnt7b were detected in normal endometrial tissues and endometrial tumours. This discrepancy of Wnt7a and Wnt7b expression in the normal endometrial cultures and tissues could be caused by the fact that NEE and NES were cultured cells and were maintained in an artificial environment, and regulatory signals that determine Wnt7a and Wnt7b expression were removed. Therefore, NES and NEE may provide good models for studying Wnt gene regulation and the factors that perturb this normal Wnt mRNA expression pattem. The levels of Wnt2, 4 and 5a mRNA were higher in stromal cells than epithelial cells, whereas the level of Wnt3 mRNA was approximately equal, suggesting the potential role of Wnt2, 4 and 5a in cell signalling between stroma and epithelia.
In comparison with normal endometrial cells, Wnt2, 3, 4 and 5a mRNAs were either absent or expressed at a very low level in endometrial carcinoma cell lines. These results indicate that the down-regulation of Wnt2, 3, 4 and 5a mRNA expression may be associated with endometrial neoplasia. It has been demonstrated that lowering of Wnt5a mRNA level in vitro will increase cell branching that resembles cell migration . Therefore, the low levels of Wnt5a mRNA expression in endometrial carcinoma cell lines and tissues were in agreement with the role of Wnt5a as a modulator of cell migration (Moon et al, 1993) . This view is further strengthened by the observation that the level of Wnt5a mRNA was extremely high in NES and NEE, and was even higher than the GAPDH mRNA level.
Wnts are a group of novel growth factors that act in an autocrine and/or paracrine manner to affect cell signalling via the cell adhesion molecules (Bradley et al, 1993; Hinck et al, 1994) . Little is known about the interaction of different Wnt members or the effect of epithelia-stroma interaction of Wnt mRNA expression.The normal endometrial cells used in this study may be a useful model for addressing these questions. In conclusion, the results presented here indicate that a subset of the human Wnt genes (Wnt2, 3, 4 and 5a) exhibited a common differential pattern of mRNA expression between normal and malignancy of the endometrium both in vitro and in vivo. Six Wnt genes (Wnt2, 3, 4, 5a, 7a and 7b) were expressed endogenously in the human endometrium, their mRNA expression was hormonally independent and Wnt4, as well as Wnt2, 3 and 5a, gene down-regulation may be associated with endometrial carcinoma. The effect of down-regulation of Wnt4 has been produced by transforming Wntl or Wnt2 in the murine mammary epithelial cell line C57MG. We are therefore assessing whether as yet unidentified overexpressed Wnt is inducing this effect.
